I like it!

$13 Million Investment by Sheikh Abdulgader Aboud Baeshen

Further to the Company’s announcement on October 6, 2020 regarding a $13 million private placement, shareholders of the Company have voted over 99% in favor of the private placement and, following discussions today, the strategic investor from Saudi Arabia, Sheikh Abdulgader Aboud Baeshen, President and CEO of Baeshen Trade, Abdulgader Baeshen Co., has confirmed completion of his due diligence, including an independent review performed by a highly-regarded international advisory firm, and his commitment to proceed with his investment.  “We are pleased with our discussions with Resverlogix and its entire team and believe in the recent Breakthrough Therapy Designation granted by the FDA; Apabetalone and its effect on cardiovascular, CKD, Alzheimer’s and COVID-19 as well as its contribution to the future of mankind,” said Sheikh Abdulgader.